Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Oct 25, 2022

SELL
$20.09 - $35.8 $58,261 - $103,819
-2,900 Reduced 78.38%
800 $0
Q2 2022

Aug 04, 2022

BUY
$27.42 - $43.63 $82,260 - $130,890
3,000 Added 428.57%
3,700 $5,000
Q4 2020

Jan 21, 2021

BUY
$79.17 - $111.47 $47,502 - $66,882
600 Added 600.0%
700 $4,000
Q2 2020

Jul 22, 2020

BUY
$54.33 - $89.52 $5,433 - $8,952
100 New
100 $0

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $499M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.